Halozyme Therapeutics, Inc. (HALO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 44.71 |
| Open | 44.85 |
| Bid | 44.97 x 200 |
| Ask | 45.11 x 100 |
| Day's range | 44.30 - 45.07 |
| 52-week range | 31.86 - 46.16 |
| Volume | |
| Avg. volume | 997,991 |
| Market cap | 5.724B |
| Beta (5Y monthly) | 1.26 |
| PE ratio (TTM) | 18.66 |
| EPS (TTM) | 2.41 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 51.78 |
ZacksHere's Why Halozyme Therapeutics (HALO) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Investor's Business DailyHalozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating
Halozyme Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 84.
ZacksHere's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
© 2024 Yahoo. All rights reserved.